BAY-1816032

N/A

Report date: 2024/10/24 14:06:15
NME

Base Information

Drug NameBAY-1816032
Drug Alias NameBAY-1816032
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitotic checkpoint serine/threonine-protein kinase BUB1 inhibitors
TargetsMitotic checkpoint serine/threonine-protein kinase BUB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A